Kovack Advisors’s Boston Scientific BSX Stock Holding History

Kovack Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$360K	Sell	5,750 -11,063	-66%	-$885K	0.02%	692
2025 Q4	$1.6M	Buy	16,813 +13,863	+470%	+$1.36M	0.07%	248
2025 Q3	$288K	Sell	2,950 -212	-7%	-$22K	0.03%	475
2025 Q2	$340K	Sell	3,162 -657	-17%	-$66.5K	0.03%	430
2025 Q1	$385K	Buy	3,819 +80	+2%	+$8.06K	0.04%	365
2024 Q4	$334K	Buy	+3,739	New	+$329K	0.03%	418
2022 Q2	–	Sell	-6,900	Closed	-$305K	–	626
2022 Q1	$305K	Buy	+6,900	New	+$299K	0.03%	525
2020 Q1	–	Sell	-9,181	Closed	-$415K	–	475
2019 Q4	$415K	Buy	9,181 +1,875	+26%	+$78.5K	0.07%	284
2019 Q3	$297K	Buy	+7,306	New	+$310K	0.06%	336
2019 Q1	–	Sell	-6,238	Closed	-$220K	–	465
2018 Q4	$220K	Buy	+6,238	New	+$226K	0.06%	325
2016 Q3	–	Sell	-10,837	Closed	-$253K	–	273
2016 Q2	$253K	Buy	+10,837	New	+$234K	0.13%	183

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kovack Advisors's BSX Position: Q1 2026 in Review

Kovack Advisors reduced its Boston Scientific (BSX) stake by 66% in Q1 2026, selling an estimated $885K and leaving 5,750 shares worth $360K. The position accounts for 0.02% of the portfolio, ranked #692.

Kovack Advisors first reported a position in BSX in Q2 2016 and has held it in 11 quarters since. The position peaked at $1.6M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Kovack Advisors held 5,750 shares of Boston Scientific worth $360K as of Q1 2026.
Kovack Advisors sold 11,063 Boston Scientific shares in Q1 2026, an estimated $885K.
Boston Scientific made up 0.02% of Kovack Advisors's portfolio in Q1 2026, its #692 holding.
Kovack Advisors first reported a position in Boston Scientific in Q2 2016 and has held it in 11 quarters since.
Kovack Advisors's Boston Scientific position peaked at $1.6M in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Kovack Advisors's 13F filing for Q1 2026, filed 13 May 2026.